Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

View the 50 largest pharmaceutical companies in the world listings here

CSL, including CSL Behring in the Drug Discovery & Development Pharma 50

CSL, including CSL Behring

Rank: 29

2021 Rank: 26

Melbourne, Australia
www.cslbehring.com

2021 Revenues ($USD) : $10,310,000,000
2021 R&D spend : $1,000,000,000
2021 Number of Employees : 25,000
Fiscal Year End : 6/30/2021
Leader : CEO Paul Perreault

CSL Behring specializes in developing plasma-derived and recombinant therapies for a range of rare and serious diseases. The company is the result of the merger between Behringwerke, founded in 1904 in Germany, and Commonwealth Serum Laboratories (CSL), founded in Australia in 1916. CSL Behring was created in 2007. Its headquarters are in King of Prussia, Pennsylvania, with parent company CSL's headquarters in Australia. In 2021, CSL Behring had strong sales of its core portfolio products, including Hizentra, a subcutaneous immunoglobulin treatment for primary immune deficiency, which was up 15%. Overall, its core immunoglobulin business grew 3%. The company’s influenza products saw especially swift growth, with sales of seasonal influenza vaccines up 41%. —BB

CSL Behring

[CSL Behring site in Pasadena, Calif. Image courtesy of CSL Behring.]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50